Precision BioSciences Inc (DTIL)
7.70
-0.38
(-4.70%)
USD |
NASDAQ |
Nov 14, 16:00
7.70
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Research and Development Expense (Quarterly): 13.08M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.08M |
| June 30, 2024 | 17.22M |
| March 31, 2024 | 13.34M |
| December 31, 2023 | 13.39M |
| September 30, 2023 | 15.85M |
| June 30, 2023 | 13.09M |
| March 31, 2023 | 11.05M |
| December 31, 2022 | 12.68M |
| September 30, 2022 | 11.76M |
| June 30, 2022 | 22.94M |
| March 31, 2022 | 19.97M |
| December 31, 2021 | 26.47M |
| September 30, 2021 | 25.94M |
| June 30, 2021 | 37.24M |
| Date | Value |
|---|---|
| March 31, 2021 | 25.59M |
| December 31, 2020 | 23.13M |
| September 30, 2020 | 24.87M |
| June 30, 2020 | 25.18M |
| March 31, 2020 | 24.88M |
| December 31, 2019 | 19.90M |
| September 30, 2019 | 19.79M |
| June 30, 2019 | 22.76M |
| March 31, 2019 | 19.96M |
| December 31, 2018 | 16.40M |
| September 30, 2018 | 9.737M |
| June 30, 2018 | 10.87M |
| March 31, 2018 | 8.117M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.05M
Minimum
Mar 2023
37.24M
Maximum
Jun 2021
19.88M
Average
19.94M
Median
Research and Development Expense (Quarterly) Benchmarks
| Assembly Biosciences Inc | 16.26M |
| TG Therapeutics Inc | 20.14M |
| Protagonist Therapeutics Inc | 35.97M |
| Alector Inc | 48.00M |
| Entrada Therapeutics Inc | 31.26M |